About the Webinar
The field of molecular cancer research is rapidly evolving with an ongoing emphasis to discover new biomarkers and DNA vaccines that can inhibit tumor progression, leading to better drugs and therapeutic outcomes. Gene synthesis and genome editing using the CRISPR-Cas9 system represents a powerful tool which can support and accelerate cancer research in the lab. In this webinar, we will highlight how gene synthesis can be a valuable and time-saving resource when investigating cancer signaling pathways, DNA vaccines, and recombinant antibodies.
About the Presenter
Kalpana Ramakrishnan is a Technical Sales Specialist at GENEWIZ supporting US and international customers who work on gene synthesis and next generation sequencing projects. She completed her Ph.D. in Cell and Molecular Biology at the University of Illinois at Chicago.